On September 1, 2023 Coherus BioSciences, Inc. ("Coherus", Nasdaq: CHRS) reported that senior management will participate in the following investor conferences (Press release, Coherus Biosciences, SEP 1, 2023, View Source [SID1234634834]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Citi’s 2023 18th Annual BioPharma Conference in Boston on Wednesday, September 6, 2023, including participation in an I-O Panel Discussion at 3:30 p.m. EDT.
2023 Wells Fargo Healthcare Conference in Boston on Thursday, September 7, 2023 for 1×1 meetings only.
H.C. Wainwright 25th Annual Global Investment Conference in New York on September 12-13, 2023 for a fireside chat-format presentation on Tuesday, September 12, 2023 at 1:30 pm EDT.
A live audio webcast and an archive of the presentations from the Citi and HCW conferences will be available on the investors’ page of the Coherus website at View Source